BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8805814)

  • 21. Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.
    Li C; Han R; Kang L; Wang J; Gao Y; Li Y; He J; Tian J
    Sci Rep; 2017 Jan; 7():40523. PubMed ID: 28091615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RAS and connective tissue in the heart.
    Sun Y; Weber KT
    Int J Biochem Cell Biol; 2003 Jun; 35(6):919-31. PubMed ID: 12676176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of locally expressed angiotensin converting enzyme in cardiac remodeling after myocardial infarction in mice.
    Aartsen WM; Schuijt MP; Danser AH; Daemen MJ; Smits JF
    Cardiovasc Res; 2002 Nov; 56(2):205-13. PubMed ID: 12393091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.
    Lal A; Veinot JP; Leenen FH
    Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cells expressing angiotensin II receptors in fibrous tissue of rat heart.
    Sun Y; Weber KT
    Cardiovasc Res; 1996 Apr; 31(4):518-25. PubMed ID: 8689643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover.
    Brilla CG; Zhou G; Rupp H; Maisch B; Weber KT
    Am J Cardiol; 1995 Nov; 76(13):8D-13D. PubMed ID: 7495221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of collagen degradation in the rat myocardium after infarction.
    Cleutjens JP; Kandala JC; Guarda E; Guntaka RV; Weber KT
    J Mol Cell Cardiol; 1995 Jun; 27(6):1281-92. PubMed ID: 8531210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin-angiotensin-aldosterone system and cardiac ischaemia.
    Ikram H
    Heart; 1996 Nov; 76(3 Suppl 3):60-7. PubMed ID: 8983666
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of the renin-angiotensin-aldosterone system on the cardiac interstitium in heart failure.
    Wilke A; Funck R; Rupp H; Brilla CG
    Basic Res Cardiol; 1996; 91 Suppl 2():79-84. PubMed ID: 8957549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy.
    Raman VK; Lee YA; Lindpaintner K
    Am J Cardiol; 1995 Nov; 76(13):18D-23D. PubMed ID: 7495212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction.
    Ju H; Zhao S; Jassal DS; Dixon IM
    Cardiovasc Res; 1997 Aug; 35(2):223-32. PubMed ID: 9349385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemic cardiomyopathy and the cellular renin-angiotensin system.
    Anversa P; Leri A; Li B; Liu Y; Di Somma S; Kajstura J
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S1-11. PubMed ID: 11016481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.
    Funck RC; Wilke A; Rupp H; Brilla CG
    Adv Exp Med Biol; 1997; 432():35-44. PubMed ID: 9433509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction.
    Geng DF; Wu W; Jin DM; Wang JF; Wu YM
    Int J Cardiol; 2006 Oct; 113(1):86-91. PubMed ID: 16891009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qishenyiqi Dropping Pill attenuates myocardial fibrosis in rats by inhibiting RAAS-mediated arachidonic acid inflammation.
    Wang J; Lu L; Wang Y; Wu Y; Han J; Wang W; Li C; Tu P
    J Ethnopharmacol; 2015 Dec; 176():375-84. PubMed ID: 26590099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models.
    Jugdutt BI; Joljart MJ; Khan MI
    Circulation; 1996 Jul; 94(1):94-101. PubMed ID: 8964124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological modulation of cardiac fibroblast function.
    Brilla CG; Maisch B; Rupp H; Funck R; Zhou G; Weber KT
    Herz; 1995 Apr; 20(2):127-34. PubMed ID: 7774864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system.
    Zhang Y; Xu S
    Chin Med J (Engl); 1995 Jan; 108(1):28-32. PubMed ID: 7712835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin-angiotensin-aldosterone system and myocardial fibrosis.
    Brilla CG
    Cardiovasc Res; 2000 Jul; 47(1):1-3. PubMed ID: 10869522
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure.
    Cittadini A; Casaburi C; Monti MG; Di Gianni A; Serpico R; Scherillo G; Saldamarco L; Vanasia M; Saccà L
    Cardiovasc Drugs Ther; 2002 May; 16(3):195-201. PubMed ID: 12374896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.